Skip to main content
Our science

Ferroptosis & Inflammation

Targeting oxidative stress and inflammation pathways to treat CNS diseases

The Ferroptosis & Inflammation platform is based on a family of enzyme targets – oxidoreductases – which are critical to the generation and regulation of energy that are key to disease pathology in the central nervous system (CNS) and other organ systems. The platform utilizes expertise in electron-transfer chemistry to modulate key biological processes beyond the reach of current drug development approaches. ​​

Ferroptosis is a recently discovered form of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides. It is genetically and biochemically distinct from other forms of regulated cell death such as apoptosis. ​​

The process of ferroptosis causes certain cell types that participate in the innate and adaptive immune response to become activated and produce pro-inflammatory cytokines. At PTC, we have grouped ferroptosis and inflammation into one platform because a hallmark of ferroptosis that is understood to cause cell death and disease progression is inflammation. ​​

Several of our current programs are targeting neuroinflammation—a critical aspect of disease pathology in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). Specifically, our compounds are designed to prevent activation of pro-inflammatory glial cells and astrocytes. Vatiquinone (PTC743) and utreloxastat (PTC857) are development-stage products that were discovered using the ferroptosis and inflammation platform.​

How does ferroptosis relate to Friedreich ataxia?

Friedreich ataxia (FA) is a rare, genetic, progressive neuromuscular disease that mainly affects the nervous systems causing muscle weakness and loss of balance and coordination. It is usually caused by the loss of a protein called frataxin which is involved in iron metabolism and essential for proper function of mitochondria, the powerhouse of all cells in the body.​

When the mitochondria are not working correctly, cells become stressed and there is an accumulation of iron and reactive oxygen species. Together these initiate a feedforward cycle of inflammation that eventually triggers ferroptosis which causes the stressed cells to die. In FA, this results in the loss of nerves and muscle. 

Read More about Ferroptosis:

Ferroptosis Q & A
May 17, 2024
What You Need to Know About Ferroptosis & Friedreich Ataxia (FA)
An Informative Q&A with Jonathan Cherry, Global Project Leader Our research efforts at PTC are focused on two scientific platforms…
Read More
Ferroptosis and Inflammation
March 20, 2024
What You Need to Know About Ferroptosis
Our research efforts at PTC are focused on two scientific platforms – splicing and ferroptosis and inflammation – where PTC has unique…
Read More